- Home
- ICCM vs GNTA Comparison
ICCM vs GNTA Comparison
Compare ICCM & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | GNTA |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | Israel | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.5M | 41.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICCM | GNTA |
|---|---|---|
| Price | $0.64 | $1.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 378.1K | 123.8K |
| Earning Date | 11-19-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,975,000.00 | N/A |
| Revenue This Year | $13.67 | N/A |
| Revenue Next Year | $38.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.59 | $1.30 |
| 52 Week High | $1.66 | $10.00 |
Technical Indicators
Market Signals| Indicator | ICCM | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.27 | 28.85 |
| Support Level | $0.67 | $1.80 |
| Resistance Level | $0.72 | $1.77 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 12.50 | 2.22 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.